The Effect of Anesthesia on Pain in Percutaneous Nephrolithotomy

Sponsor
Tugba Onur (Other)
Overall Status
Completed
CT.gov ID
NCT05467878
Collaborator
(none)
500
1
10.5
47.6

Study Details

Study Description

Brief Summary

It is aimed to determine the ideal application by determining the effect of different anesthesia methods applied in percutaneous nephrolithotomy surgeries on analgesic consumption and pain level.

Condition or Disease Intervention/Treatment Phase
  • Other: The anesthesia and analgesia technique preferred by the anesthetist will be recorded.

Detailed Description

Different anesthesia methods are used in percutaneous nephrolithotomy.In addition to traditional analgesia methods such as intravenous paracetamol, NSAIDs, opioids, various methods such as epidiural analgesia or blocks added to general anesthesia are used.In this study, it was aimed to investigate whether central or peripheral block applications are preferred in percutaneous nephrolithotomy, and the need for intraoperative and postoperative analgesics in patients.In addition, it was aimed to investigate whether there was a change in analgesic consumption, recovery and pain level, and hospital stay in patients who were given general anesthesia or regional anesthesia, in a multicentric observational manner.

Study Design

Study Type:
Observational
Actual Enrollment :
500 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
The Effect of Anesthesia on Perioperative Pain Level and Analgesic Effect in Patients With Percutaneous Nephrolithotomy
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Jan 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Group I

Patients undergoing regional anesthesia were studied. It can be in the form of combined spinal epidural or epidural anesthesia.

Other: The anesthesia and analgesia technique preferred by the anesthetist will be recorded.
In the study, the anesthesia method applied by blind anesthesiologists in the peroperative period, the drugs or techniques used for analgesia will be recorded and their effects on the postoperative period and hospital stay will be examined.There will be no intervention in the perioperative and postoperative process.

Group 2

Patients in whom general anesthesia and iv analgesic methods are preferred are in this group.

Other: The anesthesia and analgesia technique preferred by the anesthetist will be recorded.
In the study, the anesthesia method applied by blind anesthesiologists in the peroperative period, the drugs or techniques used for analgesia will be recorded and their effects on the postoperative period and hospital stay will be examined.There will be no intervention in the perioperative and postoperative process.

Group 3

Patients who prefer peripheral block under general anesthesia and ultrasound are in this group.

Other: The anesthesia and analgesia technique preferred by the anesthetist will be recorded.
In the study, the anesthesia method applied by blind anesthesiologists in the peroperative period, the drugs or techniques used for analgesia will be recorded and their effects on the postoperative period and hospital stay will be examined.There will be no intervention in the perioperative and postoperative process.

Outcome Measures

Primary Outcome Measures

  1. Visual Analog Scala (VAS) [1 days after the surgery]

    Postoperative pain levels with Visual analog Scale (VAS):Between 0 and 10 points is chosen by the patients. 0 is no pain, 10 is excessive pain.

Secondary Outcome Measures

  1. Hospital stay [after the surgery to the discharge time until 10 days]

    The time elapsed from the patients to the discharge after the operation will be recorded from the files as hours.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patient giving consent

  • accessing patient information

Exclusion Criteria:
  • missing information in the patient file

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bursa YIEAH Bursa Yildirim Turkey 16600

Sponsors and Collaborators

  • Tugba Onur

Investigators

  • Principal Investigator: Şeyda Efsun ŞE Özgünay, Assoc Prof, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Serra S Topal, MD, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Sedat S Öner, Assoc Prof, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Salim S Zengin, MD, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Şermin Ş Eminoğlu, MD, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Tuğba T Onur, MD, Bursa Yüksek İhtisas Education and Research Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tugba Onur, Medical Doctor, Bursa Yüksek İhtisas Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT05467878
Other Study ID Numbers:
  • SBÜ Bursa Hastanesi
First Posted:
Jul 21, 2022
Last Update Posted:
Jul 21, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tugba Onur, Medical Doctor, Bursa Yüksek İhtisas Education and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 21, 2022